Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.
Saved in:
| Title: | Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. |
|---|---|
| Authors: | Aguirre LE; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. luis.aguirre@yale.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. luis.aguirre@yale.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. luis.aguirre@yale.edu., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Stahl M; Department of Internal Medicine, Section of Hematology and Medical Oncology, Yale School of Medicine, New Haven, CT, USA. maximilian.stahl@yale.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Nov 04; Vol. 15 (1), pp. 192. Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01406-6 |
